Stay updated on Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.5.3 was added to the page, replacing the previous v3.5.2. This represents a small update to the page's version labeling in the Record History.SummaryDifference0.1%

- Check23 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.0 to v3.5.2. This does not indicate any change to the underlying study information.SummaryDifference0.1%

- Check52 days agoChange DetectedThe history section shows Revision: v3.5.0 as the latest entry, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded revision entry: v3.4.3; removed revision: v3.4.2 from the history.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision history updated: added v3.4.2 and removed v3.4.1.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision: v3.4.1 was added to the history. The Notice about government funding and operating status was removed.SummaryDifference0.7%

Stay in the know with updates to Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.